p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines

By Janicek M.F.   Angioli R.   Unal A.D.   Sevin B.-U.   Madrigal M.   Estape R.   Averette H.E.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 94-102

Elsevier

Access to resources Recommend Favorite

New treatment strategy for patients with EGFR-mutant lung cancer

By Ninomiya Takashi   Takigawa Nagio   Toyooka Shinichi   Hotta Katsuyuki   Tanimoto Mitsune   Kiura Katsuyuki  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 505-516

Future Medicine

Access to resources Recommend Favorite

Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors

By Liang Yayun  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 407-420

Springer Publishing Company

Access to resources Recommend Favorite

Improving cancer therapy by non-genotoxic activation of p53

By Lain S.   Lane D.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1053-1060

Elsevier

Access to resources Recommend Favorite

In VivoStudies of Adenovirus-Based p53 Gene Therapy for Ovarian Cancer

By von Gruenigen V.E.   Santoso J.T.   Coleman R.L.   Muller C.Y.   Miller D.S.   Mathis J.M.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite